Long-Term Efficacy of Abrocitinib For Atopic Dermatitis: 96 Week Results of the JADE EXTEND Study Comparing Patients Receiving Monotherapy With Those Receiving Combination Therapy Including Topical Medications.
- DOI
- 10.1016/j.jaad.2026.09.089
- Published
- 2026 Sep 26
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2026.09.089,
title = {Long-Term Efficacy of Abrocitinib For Atopic Dermatitis: 96 Week Results of the JADE EXTEND Study Comparing Patients Receiving Monotherapy With Those Receiving Combination Therapy Including Topical Medications.},
author = {Geng B and Deleuran M and Prajapati VH and Tanaka A and Fukumoto T and Biswas P and Koppensteiner H},
year = {2026},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2026.09.089},
url = {https://doi.org/10.1016/j.jaad.2026.09.089}
}RIS
TY - JOUR TI - Long-Term Efficacy of Abrocitinib For Atopic Dermatitis: 96 Week Results of the JADE EXTEND Study Comparing Patients Receiving Monotherapy With Those Receiving Combination Therapy Including Topical Medications. AU - Geng B AU - Deleuran M AU - Prajapati VH AU - Tanaka A AU - Fukumoto T AU - Biswas P AU - Koppensteiner H PY - 2026 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2026.09.089 UR - https://doi.org/10.1016/j.jaad.2026.09.089 ER -
APA
B, G., M, D., VH, P., A, T., T, F., P, B., & H, K. (2026). Long-Term Efficacy of Abrocitinib For Atopic Dermatitis: 96 Week Results of the JADE EXTEND Study Comparing Patients Receiving Monotherapy With Those Receiving Combination Therapy Including Topical Medications.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.089
Source records
- pubmed · retrieved 2026-09-27T09:55:21.214Z